Because D40 siRNA can inhibit tumor growth and induce apoptosis regardless of the p53 status, D40 siRNA may be able to inhibit the growth of tumors that have become resistant to molecular targeted drugs, such as EGFR inhibitors. The gene discussed is TP53; the disease is neoplasm.